加拿大第一民族和非第一民族男性前列腺癌结局的差异-队列研究
Patrick Albers1, Khalid Amin2, Stacey Broomfield1
1Division of Urology, Department of Surgery, University of Alberta, Canada.
Lancet regional health. Americas
|February 23, 2026
概括
阿尔伯塔省的第一民族男性面临更早的前列腺癌诊断和更高的死亡率. 虽然疾病特异性生存率相似,但差异表明,延迟检测需要文化敏感的外展,以便更早地进行查.
科学领域:
- 瘤学和公共卫生
- 原住民的健康差异
- 癌症流行病学 癌症流行病学
背景情况:
- 与非第一民族男性相比,加拿大的第一民族男性患上更具侵略性的前列腺癌.
- 前列腺癌的结果和阿尔伯塔省这些群体之间的生存差异需要进一步调查.
研究的目的:
- 检查阿尔伯塔省第一民族和非第一民族男性之间的前列腺癌结果差异.
- 分析诊断年龄,死亡率和生存率的差异.
主要方法:
- 对被诊断患有前列腺癌的男性的阿尔伯塔癌症登记数据 (1995-2022) 的分析.
- 通过阿尔伯塔省医疗保险计划登记处确定原住民身份.
- 包括生存曲线和Cox比例危险模型在内的统计分析,并指出缺乏社会经济数据.
主要成果:
- 原住民男性的诊断年龄较小 (65.8岁对67.8岁),死亡率较高 (41.5岁对每10万人的30.1岁) 和更多的第四阶段疾病 (17.8%对12.2%).
- 原住民男性的前列腺癌特异性存活率更差 (HR 1.67),但调整后的整体存活率相似.
- 根据年龄,阶段,位置和恶性瘤的数量进行控制的调整分析.
结论:
- 阿尔伯塔省的第一民族男性在诊断时年龄较小,晚期疾病和整体死亡率较高.
- 虽然调整后的疾病特异性存活率相似,但差异突出显示了延迟诊断的影响.
- 文化安全,社区知情的倡议对于促进在第一民族社区提前呈现和检测至关重要.
相关概念视频
01:20Disorders of the Male Reproductive System
5.2K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.2K
01:29Bias in Epidemiological Studies
1.4K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.4K
01:21Cancer Survival Analysis
793
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
793
01:08Prevalence and Incidence
2.0K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
2.0K
01:27Confounding in Epidemiological Studies
888
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
888
01:20Comparing the Survival Analysis of Two or More Groups
652
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
652